Features

Introduction

Change is inevitable. As the 21st century advances, Singapore faces a wave of unprecedented challenges driven by rapid shifts across its economy and society: from an increasingly erratic climate to an ageing urban population; from new industrial sectors to the artificial intelligence (AI) revolution. To not only adapt but thrive, Research, Innovation and Enterprise (RIE) remain fundamental to the country’s future.

“RIE is a cornerstone of Singapore’s strategy to develop a knowledge-based and innovation-driven economy and society,” said John Lim, Chief Executive Officer of the National Research Foundation (NRF) Singapore.

Commenced in April 2026, Singapore’s recently announced RIE2030 Plan is structured to achieve consequential impact through large interdisciplinary, national-level initiatives, as well as major domain-level programmes. The five-year plan will also continue to actively support foundational research; maintain globally competitive research capabilities and talent; and strengthen Singapore’s position as a global technology startup node.

“We are fortunate to be able to build from a position of strength, with Singapore internationally recognised as a leading RIE centre,” said John Lim. “We must continue our efforts to advance Singapore as a great place for world-class research and scientific discovery; to turn ideas and inventions into impact; and to attract and nurture RIE talent. Our efforts are guided by a clear focus to create new economic possibilities and growth for Singapore, and to drive positive societal impact for Singapore and beyond.”

As Singapore’s strategic innovation engine, A*STAR is gearing up for RIE2030 across its vertical domains and horizontal enablers, with efforts encompassing talent recruitment, interdisciplinary R&D initiatives and wider ecosystem collaboration.

“We need the best people working together across institutions and sectors for Singapore to have its best chances at excelling globally, being attractive as a strategic partner, and creating even greater impact,” said Chorh Chuan Tan, A*STAR Chairman.

A*STAR Chief Executive Officer Kian Teik Beh emphasised the importance of moving beyond pushing technology to letting real-world needs pull science forward, aligning with national strategic priorities. “A*STAR must deepen the pathways that carry research through to real-world application, ensuring that our work translates into tangible outcomes across healthcare, industry and society,” said Beh.

Strong foundations, new directions

RIE2030 will sustain fundamental elements of RIE2025, including a committed investment of about one percent of Singapore’s GDP, amounting to S$37 billion. It will also maintain RIE2025’s four vertical domains—Manufacturing, Trade and Connectivity (MTC); Human Health and Potential (HHP); Urban Solutions and Sustainability (USS); and Smart Nation and Digital Economy (SNDE)—with Academic Research and Talent as the key horizontal enablers.

New to RIE2030 are RIE Flagships and RIE Grand Challenges: national interdisciplinary programmes that respectively aim to advance the economy in key sectors such as semiconductors, and to pull through coordinated research to address national strategic challenges such as healthy ageing and decarbonisation.

“We intend to implement actively managed programmes at sufficient scale and intensity to drive greater impact, compared to smaller, potentially disparate programmes that could be individually meaningful but have less collective impact,” said John Lim.

A second priority area is to build well-coordinated, cutting-edge Data-AI-Compute (DAC) capabilities to accelerate and boost research and innovation. Directed by comprehensive national AI, research data and compute strategies, DAC capabilities will be a key enabler of both national-level initiatives and domain-level major programmes in RIE2030 and beyond.

A third shift is the deeper integration of Innovation and Enterprise (I&E) into each domain rather than as a separate third horizontal, enabling end-to-end, sector-specific I&E strategies to be developed for each domain. At A*STAR, robust venture building frameworks such as the Entrepreneur Partners Program (EPP) and Venture Atelier Partners (VAP) will pair differentiated intellectual property (IP) with experienced entrepreneurs, providing structured pathways to advance technologies and develop global deep tech spinoffs.

“The NRF will continue to support early-stage research translation efforts across all fields and sectors, while the Ministry of Trade and Industry (MTI) will administer schemes to support enterprise innovation activities and scaling,” said John Lim.

As Singapore’s leading public sector R&D agency, A*STAR will play a significant role across RIE2030. The following sections feature leadership insights on the agency’s strategic directions for RIE2030’s four vertical domains and Talent horizontal.

Domain: Manufacturing, Trade and Connectivity

Under RIE2030, A*STAR’s MTC portfolio will prioritise strategic sectors of high economic importance, such as semiconductors, advanced manufacturing and connectivity, with resources aligned to create clearer pathways to adoption and impact, according to Keng Hui Lim, Assistant Chief Executive of A*STAR’s Science and Engineering Research Council (SERC).

“A*STAR will place a stronger emphasis on deep collaborations with Quality Partners (QPs): both multinational companies (MNCs) and promising growth companies that will adopt, scale and invest further in Singapore,” Keng Hui Lim added. “In parallel, we will continue to support and uplift small and medium enterprises (SMEs) through defined pathways—including tech adoption, supply chain integration and capability uplift—while maintaining the flexibility to seize emerging opportunities from scientific breakthroughs.”

In the semiconductors sector, A*STAR’s work will be anchored by RIE2030’s first RIE Flagship, as well as the National Semiconductor Translation and Innovation Centre (NSTIC), with a strong focus on heterogeneous integration and silicon photonics. (see inset: “RIE Flagship 1”)

“Our work on piezoelectric microelectromechanical systems (PiezoMEMS), flat optics, gallium nitride-based radio frequency (RF GaN), power electronics, and RF and cryogenic integrated circuit design will also support emerging application areas ranging from next-generation communications and sensing systems to electrification and advanced computing,” said Yee Chia Yeo, Deputy Chief Executive of A*STAR Innovation and Enterprise (I&E).

A*STAR will also leverage its semiconductor platforms to build capabilities in niche areas of quantum sensors and photonics, such as on-chip light sources for photonic quantum computers, as well as levitation-based quantum sensors resilient to environmental disruptions.

For advanced manufacturing, Keng Hui Lim added that A*STAR will focus on supporting national goals to anchor high-value advanced manufacturing locally while positioning Singapore as a manufacturing innovation hub for Southeast Asia.

“We will build on the agency’s track record of measurable productivity and value-added impact, and mobilise whole-of-agency capabilities to drive shopfloor productivity, strengthen local supply chains, co-develop new products with companies, and begin regionalising efforts,” said Keng Hui Lim.

In the connectivity sector, A*STAR’s Hub of the Future (HOTF) central framework aims to support Singapore as a global air, sea and land transport and logistics hub through innovation for efficiency, sustainability and resilience, working in close partnership with public agencies and industry players.

“A*STAR will raise ambitions for needle-moving real-world outcomes while continuing to sustain strong scientific excellence in MTC,” said Keng Hui Lim. “We will build on what worked in RIE2025: strong translational capabilities, ecosystem partnerships and solutions that address industry needs.”

RIE Flagship 1: Semiconductors

Singapore’s semiconductor industry accounted for an estimated 10 percent of global chip production, six percent of national GDP and 35,000 jobs in 2025, according to the Singapore Economic Development Board (EDB).

Co-led by A*STAR and EDB, and working with autonomous institutes of higher learning (IHLs), the Semiconductor RIE Flagship programme aims to strengthen Singapore's strategic importance as an R&D node in the global semiconductor supply chain, deepening its capabilities in high-impact technology areas and growing globally competitive local companies and deep tech startups.

“With AI, high-performance computing (HPC) and electrification placing greater pressure on how chips handle data, power and heat, Singapore’s strongest opportunities lie in areas where semiconductor performance increasingly depends on system integration and data movement rather than transistor scaling alone,” said Yeo. “Rather than replicate the logic scaling race of the largest semiconductor manufacturers, we can harness our strengths in integration and translational R&D.”

The Flagship will create a broader national structure that aligns research institutes, infrastructure and industry partnerships under shared priorities and delivery milestones. “A*STAR plays a central driving role in this, giving Singapore more room to organise capabilities and engage additional partners as industry needs evolve,” Yeo added.

Research institutes such as the A*STAR Institute of Microelectronics (A*STAR IME) and A*STAR Institute of Materials Research and Engineering (A*STAR IMRE) will anchor A*STAR’s core research and engineering capabilities, while NSTIC will serve as a national translation platform to bring those capabilities into industry-facing development and deployment.

MTC in RIE 2030: A*STAR highlights

Semiconductors

• RIE Flagship: National programme to unite ecosystem capabilities in heterogenous integration, silicon photonics and other critical semiconductor technologies, expanding high-value research and manufacturing.
• NSTIC: A*STAR-hosted national platform in flat optics and advanced photonics R&D, in partnership with IHLs.

Advanced Manufacturing

• Joint Labs with QPs: Paired with SME-MNC supply chain integration efforts to uplift factories and strengthen local ecosystem capabilities; and to support local SMEs to become product owners and venture into high-value markets globally.
• Sectoral AI Centre of Excellence for Manufacturing (AIMfg): National centre driving manufacturing plant rejuvenation and digital/AI transformation.
• Deeper IHL partnerships: To strengthen longer term, low translational readiness level (TRL) manufacturing research capabilities and sustain breakthrough innovation.
• Embodied AI (EAI) and robotics: To augment workforces in physically demanding and highly complex tasks, focused on advanced manufacturing, airport and seaport operations.

Connectivity / Hub of the Future (HOTF)

• Maritime: Doubling down on AI-enabled outcomes for just-in-time, fuel-efficient operations, including vessel near-miss detection and arrival time estimation tools. Advancing deployment and licensing to maritime operators and companies.
• Land: Scale up trials of CRUISE intelligent traffic management system; industry collaboration for potential overseas export and deployment.
• Aviation: Development of total airport management platform for new operating concept trials; supporting Changi Airport in operational growth paradigms without commensurate manpower increases.

Domain: Human Health and Potential

Precision population health, the optimisation of lifelong human potential, and biomedtech and biomanufacturing form the key thrusts of RIE2030’s HHP domain, which includes the first RIE Grand Challenge: maximising healthy and successful longevity. (see inset: “RIE Grand Challenge 1”)

“A*STAR’s RIE2030 HHP strategy is distinguished by a sharper alignment to population-level impact and life-course optimisation, broadening our focus beyond disease management,” said Lisa Ooi, Assistant Chief Executive of A*STAR’s Biomedical Research Council (BMRC). “A strengthened Precision Health Strategy will build on RIE2025’s translational foundations, focused on extending healthspan across our population.”

Leveraging A*STAR’s core strengths in biomedical sciences, multi-omics, data science and AI, the agency will work closely with longitudinal Asian cohorts and national initiatives to develop large-scale multimodal datasets anchored in Singapore’s population, supported by secure data environments and trusted governance frameworks.

“By integrating biological, behavioural and environmental data at scale, A*STAR aims to generate actionable insights that inform preventive strategies, refine risk-prediction tools, and guide targeted interventions tailored to Asian populations,” Ooi added.

High-value therapeutics are another priority area under RIE2030. A*STAR will adopt a portfolio-based therapeutics strategy, organised around priority disease areas and intervention modalities.

“In the near term, we will harvest existing programmes and catalyse spinoff generation through differentiated assets and venture capital (VC)-investible data packages. Over a five-year horizon, we will develop capabilities and programmes with clear sightlines toward generating future substrates for globally investible assets and platforms,” said Ooi. “A portion of our portfolio remains dedicated to novel technologies, biology and mechanisms that seed future therapeutics.”

A*STAR will also continue to emphasise medtech, having significantly contributed to the sector’s growth since 2010 by generating over 40 spinoff companies valued at over S$1 billion, building global partnerships, and seeding national initiatives to meet translation and talent gaps, such as the Diagnostics Development Hub (DxD Hub), MedTech Catapult (MC) and Singapore Biodesign (SB).

“Looking ahead, A*STAR will anchor Singapore as a leading global medtech ecosystem by creating a flywheel of value creation through a sustainable ‘Build-to-Buy’ model that creates high-value substrates that are attractive to VC groups, Venture Builders and QPs,” said Irene Cheong, Assistant Chief Executive of A*STAR I&E.

Cheong added that A*STAR will expand DxD Hub and MC as commercialisation engines by enhancing their venture acceleration, market access and clinical evidence generation capabilities. This will enable groups working with them to reach significant valuation uplifts, drive adoption and revenue generation, and bring faster benefits to patients. A coordinated financing continuum with a clear commercial end-in-mind will also be established through these initiatives, pulling upstream RIE grants through to government-linked financing for strong commercial and patient outcomes.

“We will also double down on Tier-1 QPs for outsized value creation and value capture, particularly for AI and digital transformation needs,” said Cheong.

Beyond these areas, A*STAR will also contribute to broader national priorities, including the bioeconomy and pandemic preparedness. “We will continue to advance capabilities in biotechnology, synthetic biology and biomanufacturing that support economic diversification, resource resilience and new industrial value chains,” said Ooi. “We will also strengthen capabilities in pandemic preparedness, including vaccines, pathogen surveillance and scalable manufacturing, to enable rapid national response in close collaboration with public agencies and healthcare partners.”

RIE Grand Challenge 1: Maximising Healthy and Successful Longevity

As of 2026, Singapore has become a super-aged society, with more than 20 percent of its population being 65 years or older. “This programme aims to generate research insights for developing targeted interventions—both health and socio-environmental—that support healthy and successful ageing by supporting brain health and physical function while slowing the onset and progression of cognitive and physical decline,” said John Lim.

To support efforts in this area, Lisa Ooi noted the agency will catalyse industry partnerships and pilot AI-enabled screening and risk stratification tools in the near term. A*STAR will also deepen existing collaborations with ministries, agencies and healthcare clusters to validate and scale up preventive interventions, aligned with national health strategies and care delivery systems.

“Over the long term, our ambition is to position Singapore as a trusted translational research ecosystem for population-scale preventive health and healthy longevity, shifting healthcare policy and practice while attracting high-value industry partnerships,” said Ooi.

HHP in RIE2030: A*STAR highlights

Precision population health

• RIE Grand Challenge 1: Coordinated research for targeted preventive interventions, evidence-based policy and practice, and deployment-ready solutions for a healthy and successful ageing population.
• Asian longitudinal cohorts: Greater integration and deployment of insights on determinants of Asian health, performance and mental well-being from early development (GUSTO, S-PRESTO, SG-LEADS, iAdore) and life-course studies (SLAS, SCHS), in collaboration with the National Precision Medicine (NPM) Programme.
• TRUST¹ platform: A connected and secure HHP data ecosystem linking research and longitudinal real-world clinical datasets. Hosted at A*STAR and managed in close partnership with the Biomedical Data Hub and National Cohorts Office.

Therapeutics

• National translational platforms: Bridging discovery and partnership-ready asset creation via the Singapore Therapeutics Development Review (STDR), Experimental Drug Development Centre (EDDC) and Nucleic Acid Therapeutics Initiative (NATi).

Medtech

• MedTech Innovation Development and Acceleration Scheme (MIDAS): Competitive grants enabling DxD Hub and MC to direct upstream R&D, strengthening early-stage pipelines.
• National commercialisation engines: Venture acceleration, market access and productisation-focused support via DxD Hub and MC, helping diagnostics, digital health, medtech devices and life science tools reach markets faster with clinician adoption for patient benefits.
• Ecosystem development: Dedicated innovation talent programmes via SB, and active public-private partnership facilitation between QPs, clinical groups and researchers via the Biomedical Sciences Industry Partnership Office (BMSIPO).

BioMedtech

• HHP MISSION: Mission-driven translation model, shifting from individual principal investigator-driven projects to coordinated challenge-led programmes that target industry-relevant bottlenecks.

Domain: Smart Nation and Digital Economy

To support Singapore’s National AI Strategy 2.0 and National Quantum Strategy, AI and quantum capabilities will be the primary drivers of A*STAR’s SNDE efforts for RIE2030. “The shift towards AI is particularly critical as Singapore positions itself as a global AI leader and aims to harness AI’s strategic advantages through coherent solution deployments,” said Keng Hui Lim.

At A*STAR, a key SNDE hub will be a new Compute Intelligence R&D Institute² that consolidates the A*STAR Institute of High Performance Computing (A*STAR IHPC) and A*STAR Institute for Infocomm Research (A*STAR I²R). Keng Hui Lim noted that the organisational shift will better connect foundational compute and AI capabilities with real sector outcomes, harnessing deep collaborations with domain experts in manufacturing, materials science, healthcare and others.

“By bringing A*STAR’s DAC capabilities under one roof, the new institute will form the bedrock of our RIE2030 aspirations in advanced intelligence and computing so as to deliver impact at speed and scale,” said Keng Hui Lim. “It will accelerate the development of digital workflows and reusable digital assets, enabling same-day intelligence, first-time-right impact, and safe and trustworthy deployment in key sectors, all while strengthening platforms for our broader DAC ambitions.”

The agency will also maintain its core strengths in digital intelligence and computing with domain expertise (AI-for-X) for key sectors such as advanced manufacturing, semiconductors, connectivity and digital services.

“We aim to deepen our capabilities in data management, AI engineering, HPC optimisation and hybrid computing, expanding them across A*STAR for cross-domain deployment and impact,” said Keng Hui Lim.

Spotlight: Data-AI-Compute (DAC)

RIE2030 aims to develop DAC capabilities under the following strategic umbrellas:

Data: National Research Data Strategy to enable expeditious and safe access to deidentified government and strategic publicly funded research datasets; enhance and scale TRUST; and expand TRUST to support non-health research data.

AI: AI for Science³ and Applied AI initiatives under the National Artificial Intelligence R&D (NAIRD) Plan to act as amplifiers to accelerate and boost research and innovation, leveraging outcomes from specific workstreams to build peaks of basic AI research excellence.

Compute: National Research Compute Strategy under development to map how to leverage and build leading capabilities in classical HPC, hybrid computing and quantum computing.

SNDE in RIE2030: A*STAR highlights

Hybrid quantum-classical computing

• Advanced R&D: Development of cross-cutting capabilities and technology platforms by the National Quantum Computing Hub (NQCH) co-led by the new Compute-Intelligence R&D Institute at A*STAR, as part of the National Quantum Strategy.
• Use-case development: Drug discovery, financial optimisation, logistics and other potential high-impact use cases in collaboration with companies.

AI for Science

• Acceleration of scientific discovery: Advanced computing technologies such as generative AI, autonomous experimental labs, AI surrogate models and HPC acceleration for materials science and other fields, providing horizontal functions across A*STAR.

Digital trust and security

• Safe and trustworthy systems: Development and deployment of tools to prevent, detect and mitigate harmful online content through the Centre for Advanced Technologies in Online Safety (CATOS).

National LLM development and digital services

• MERaLiOn LLM programme: Advancement to global leadership in open-source conversational AI for Southeast Asian languages and in human-AI interaction. Next phase to broaden capabilities and industry engagement in visual intelligence, expressive speech generation and agentic AI.

Domain: Urban Solutions and Sustainability

As a small yet densely urbanised island nation with limited natural resources, Singapore faces rising sea levels, extreme weather and other sustainability challenges posed by climate change. As such, USS in RIE2030 will focus on advancing decarbonisation, strengthening climate resilience, and building a sustainable and liveable Singapore.

“A*STAR will maintain its interdisciplinary strengths—particularly in AI and autonomous experimental labs; techno-economic analysis (TEA) and life cycle assessment (LCA); and process engineering and scale-up—to guide technology selection, R&D investment and pilot deployment in this domain,” said Keng Hui Lim.

With RIE2030’s second RIE Grand Challenge placing the spotlight on decarbonisation, A*STAR efforts under USS will focus on supporting national emissions reduction targets and the transition of key industrial ecosystems (see inset: “RIE Grand Challenge 2”).

“A*STAR’s decarbonisation thrust for RIE2030 will target CO₂ abatement through R&D pilots spanning carbon capture and utilisation, alternative energy carriers, low-carbon hydrogen and industrial safety standards,” added Keng Hui Lim. “Our overall approach is framed as a technology-industry-public sector collaboration model which will catalyse robust value chains and downstream adoption of technological solutions.”

RIE Grand Challenge 2: Decarbonisation

In 2020, Singapore ratified a United Nations climate pledge to achieve net zero greenhouse gas (GHG) emissions by 2050. To help the nation meet its climate commitments, the Decarbonisation RIE Grand Challenge (DGC) will support research, innovation and translation efforts in low-carbon energy generation and industrial process decarbonisation.

Led by MTI, the S$800 million programme will focus on potential technologies to decarbonise industrial and power sectors at scale, as these areas account for over 80 percent of Singapore’s GHG emissions.

Under DGC, the Singapore Pilots for Energy and Enterprise Decarbonisation (SPEED) programme will be launched to develop promising solutions into commercially deployable ones in service of Singapore’s climate goals. Hosted by A*STAR, SPEED will bring together stakeholders across Singapore’s climate tech ecosystem to pilot and support promising innovations.

USS in RIE 2030: A*STAR highlights

Decarbonisation

• RIE Grand Challenge 2: Coordinated research for power and industry decarbonisation, and scaling up promising technologies that address Singapore’s national imperative (SPEED programme).
• CO₂ capture and utilisation: Exploring solutions such as conversion and mineralisation of incinerated ash waste into alternative building materials, in collaboration with power generation and waste management companies.
• Low-carbon hydrogen: Development of low-cost, low-carbon hydrogen production technologies (e.g., methane cracking, ammonia cracking) for power generation. Catalysed through platforms such as the ExxonMobil-Nanyang Technological University-A*STAR Corporate Laboratory.
• Industrial safety measures and standards development: Partnerships with relevant agencies and companies to create comprehensive guidelines and rigorous standards for large-scale handling of alternative energy carriers such as ammonia.
• Process engineering and technology scale-up: Upcoming Low-Carbon Technology Translational Testbed (LCT³) on Jurong Island to offer cost-effective modular testbeds for emerging low-carbon technologies. LCT³ is based at the A*STAR Institute of Sustainability for Chemicals, Energy and Environment (A*STAR ISCE²).
• Modelling and simulation: Centre for Energy and Emissions Modelling (CE2M), National Climate Change Secretariat, other government agencies and IHLs to collaborate on integrated modelling to inform decarbonisation policies, and assess net zero tradeoffs and synergies between power, industry and transport sectors.

Horizontal: Talent

Good science and great talent underpin an RIE ecosystem at any scale. As such, RIE2030’s Talent horizontal aims to grow a strong and diverse talent base in research, translation and innovation, as well as nurture tomorrow’s leaders in these areas.

“A*STAR’s talent strategy critically serves not just the agency, but Singapore as a whole,” said Andy Hor, A*STAR Deputy Chief Executive (Research). “It must consider not only those who remain in research, but those who develop other skillsets and interests over time, moving into management, entrepreneurship, industry, IHLs or the public sector. It must also consider how talents will fit in with, and contribute to, future national strategic needs.”

Hor added that A*STAR will continue to invest in and develop a strong local talent core enriched by top global talents; recruit across a wide spectrum of fields including life sciences, physical and natural sciences, engineering and computer science; and seek quality talent with established track records or outstanding potential.

“For RIE2030, there will be a sharper focus on priority R&D areas such as AI, semiconductors, biomedtech and decarbonisation,” said Hor. “We’re also increasing our investment in innovation and entrepreneurial talent to incentivise and support startups and spinoffs; and mounting stronger recruitment efforts for bilingual talents with interest in research, entrepreneurship and programme management.”

Hor added that research is a key pillar in RIE2030, but not the only one. A*STAR will encourage local and global talents to consider their work in deeper and longer timeframes, aiming to support RIE2030’s entire value chain, which also includes its innovation and enterprise mandates.

“Research talents must subscribe to the innovation spirit, aiming for meaningful impact on societies, systems or communities,” said Hor. “Enterprise is also fundamental, as its growth depends on talent that can help industries address future challenges and move into new products, services and businesses.”

Talent in RIE2030: A*STAR highlights

Renewed focus on:

• NRF Fellowships and Investigatorships: Leveraging ecosystem RIE talent development programmes to support independent research by early to mid-career researchers in A*STAR; and high-impact, high-risk research by A*STAR’s research leaders.
• A*STAR Scholarships: Continuing a 25-year track record of developing top local talents at A*STAR institutes, and supporting their exploration of wider RIE ecosystem opportunities.
• Global talent scouting: Harnessing A*STAR’s global network of universities, research institutions and organisations to bring talents in basic science, translation and industry into Singapore’s local ecosystem.

New programmes:

• NRF Postdoctoral Award: Enables the recruitment of high-potential young talents to conduct independent postdoctoral research while preparing for longer-term appointments.
• A*STAR Early Career Researcher (ECR) Overseas Exchange Fellowship: Two-way avenue for ECRs from Singapore and abroad to join leading international research environments, so as to develop capabilities, facilitate collaborations, understand global benchmarks and keep abreast of global developments in strategic RIE areas. Currently in the pipeline.
• Singapore-Southeast Asia Fellowship (S-SEAF): National scheme to promote regional talent mobility and capability development, enabling inbound and outbound postdoctoral researcher exchange between Singapore and ASEAN countries. Coordinated by A*STAR from 2026 onward.
• A*STAR Entrepreneurial Investigatorship (EI): Kickstarts entrepreneurial researchers who aim to lead novel, high-impact translational projects, with tailored support for innovation, venture building and commercialisation.